✦ LIBER ✦

Quantitative progesterone receptor activity (PGR) and response to first endocrine therapy in advanced breast cancer

✍ Scribed by Hervás-Ontiveros, A.; España-Gregori, E.; Hernández-Martínez, P.; Vera-Sempere, F.J.; Díaz-Llopis, M.

Book ID: 121916730
Publisher: Elsevier Science
Year: 1986
Weight: 178 KB
Volume: 22
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(86)90231-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progesterone receptor activity (PgR) and

Progesterone receptor activity (PgR) and response to first endocrine therapy in advanced breast cancer: Significance of timing of receptor analysis

📂 Article 📅 1986 🏛 Elsevier Science ⚖ 178 KB

Progesterone receptor activity and the r

Progesterone receptor activity and the response to the first endocrine therapy in advanced breast cancer

✍ Raemaekers, John M.; Beex, Louk V.; Pieters, Gerlach F.; Smals, Anthony G.; Benr 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 556 KB

Oestrogen and progesterone receptors and

Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer

✍ Y. Nomura; O. Takatani; H. Sugano; K. Matsumoto 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Activated oestrogen receptors in breast

Activated oestrogen receptors in breast cancer and response to endocrine therapy

✍ Dolores Fernandez, M.; Ian Burn, J.; Sauven, Paul D.; Parmar, Girish; White, Joh 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 623 KB

Oestrogen receptors and the response to

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer1

✍ Roberts, M M; Rubens, R D; King, R J; Hawkins, R A; Millis, R R; Hayward, J L; F 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 795 KB

Estrogen and progesterone receptors in t

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

✍ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to